COMP <GO>
MEDS vs HKPD // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
DataMeds AI Inc. (NASDAQ) VS. Cellyan Biotechnology Co. Ltd (Class A) (NASDAQ) • 15-METRIC TALLY: MEDS 1
— HKPD 1
■ METRIC PARITY
LAST: $1.92 (-5.42%) • MKT CAP: $9.8M
options-implied-move
—
LAST: $1.98 (-9.59%) • MKT CAP: $5.4M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MEDS VS. HKPD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MEDS | HKPD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -27.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 28.70% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.1 | 43.5 | -2.40 | HKPD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.8M | $5.4M | $4.4M | MEDS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MEDS REV | HKPD REV | MEDS GROSS % | HKPD GROSS % | MEDS FCF | HKPD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.3M | — | -27.5% | — | -$10.9M | — |
| FY 2024 | $18.1M | — | 9.7% | — | -$1.2M | — |
| FY 2023 | $0 | — | — | — | -$349.1K | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MEDS // BETA —
HKPD // BETA —